{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:33:59Z","timestamp":1775568839871,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1621,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Korean Society of Pediatric Hematology-Oncology"},{"name":"Korea Healthcare Technology R&D Project, Ministry of Health, Welfare and Family affairs, Republic of Korea","award":["A070001"],"award-info":[{"award-number":["A070001"]}]},{"DOI":"10.13039\/501100004332","name":"SNUH","doi-asserted-by":"crossref","award":["03-2007-020"],"award-info":[{"award-number":["03-2007-020"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.bbmt.2010.05.010","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T10:04:25Z","timestamp":1274954665000},"page":"1582-1588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Successful Engraftment with Fludarabine, Cyclophosphamide, and Thymoglobulin Conditioning Regimen in Unrelated Transplantation for Severe Aplastic Anemia: A Phase II Prospective Multicenter Study"],"prefix":"10.1016","volume":"16","author":[{"given":"Hyoung Jin","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nak Gyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hack Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Tak","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keon Hee","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Woong","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Hoe","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Joon","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Jin","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Seop","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.05.010_bib1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","article-title":"Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia","volume":"84","author":"Storb","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib2","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1182\/blood-2006-10-052308","article-title":"Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens","volume":"109","author":"Champlin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib3","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1182\/blood.V83.11.3417.3417","article-title":"Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors","volume":"83","author":"Deeg","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/bbmt.2001.v7.pm11349807","article-title":"Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation","volume":"7","author":"Deeg","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1182\/blood-2006-03-005041","article-title":"Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy","volume":"108","author":"Deeg","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bmt.1705165","article-title":"Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party","volume":"36","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1701991","article-title":"Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation","volume":"24","author":"Remberger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib8","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/00007890-200005150-00026","article-title":"Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines","volume":"69","author":"Zuckermann","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.05.010_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/TP.0b013e318187bc67","article-title":"A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results","volume":"86","author":"Hardinger","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.05.010_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1704720","article-title":"Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia","volume":"34","author":"Kang","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1703306","article-title":"Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)","volume":"28","author":"Bacigalupo","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/bmt.2009.151","article-title":"Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants","volume":"45","author":"Bacigalupo","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib13","series-title":"Thomas' Hematopoietic Cell Transplantation","first-page":"981","article-title":"Allogeneic hematopoietic cell transplantation for aplastic anemia","author":"Georges","year":"2004"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2010.05.010_bib14","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1038\/bmt.2008.293","article-title":"Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia","volume":"42","author":"Fuhrer","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2141.2001.02992.x","article-title":"Unrelated donor marrow transplantation in children with severe aplastic anaemia using cyclophosphamide, anti-thymocyte globulin and total body irradiation","volume":"114","author":"Kojima","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.05.010_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1365-2141.2001.02993.x","article-title":"Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath","volume":"114","author":"Vassiliou","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.05.010_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.bbmt.2007.03.013","article-title":"Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide","volume":"13","author":"Kim","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib18","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3324\/haematol.2009.007583","article-title":"Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review","volume":"94","author":"Peinemann","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.05.010_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.2000.02452.x","article-title":"Late outcomes after bone marrow transplant for aplastic anaemia","volume":"111","author":"Eapen","year":"2000","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2010.05.010_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03165081","article-title":"Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation","volume":"76","author":"Sanders","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2010.05.010_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood.V78.2.277.277","article-title":"Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia","volume":"78","author":"Socie","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM199310143291603","article-title":"Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party","volume":"329","author":"Socie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2010.05.010_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1702768","article-title":"A fludarabine-based conditioning regimen for severe aplastic anemia","volume":"27","author":"Chan","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bmt.1705321","article-title":"Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia","volume":"37","author":"Kumar","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/bmt.2008.390","article-title":"Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD","volume":"43","author":"Novitzky","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib26","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bmt.1703374","article-title":"Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors","volume":"29","author":"Remberger","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","article-title":"Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib29","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.bbmt.2009.08.012","article-title":"Tacrolimus\/Methotrexate versus cyclosporine\/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis","volume":"15","author":"Yagasaki","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bbmt.2006.07.011","article-title":"Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia","volume":"12","author":"Kennedy-Nasser","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.010_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3324\/haematol.10899","article-title":"Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient","volume":"92","author":"Maury","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.05.010_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.05.010_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","article-title":"Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib35","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1182\/blood-2007-10-118372","article-title":"A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation","volume":"112","author":"Gajewski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib36","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","article-title":"Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation","volume":"109","author":"Armand","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.05.010_bib37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bmt.2009.88","article-title":"Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children","volume":"44","author":"Lee","year":"2009","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:38:22Z","timestamp":1761057502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110002223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1083879110002223"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.05.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Engraftment with Fludarabine, Cyclophosphamide, and Thymoglobulin Conditioning Regimen in Unrelated Transplantation for Severe Aplastic Anemia: A Phase II Prospective Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}